Ellogon AI Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Ellogon AI and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 400 Ellogon AI employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Ellogon AI has purchased the following applications: UbiOps for ML and Data Science Platforms in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Ellogon AI is running and its propensity to invest more and deepen its relationship with UbiOps or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Ellogon AI revenues, which have grown to $88.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Ellogon AI intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
AI Development
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| UbiOps | Legacy | UbiOps | ML and Data Science Platforms | AI Development | n/a | 2022 | 2023 |
In 2022, Ellogon AI deployed UbiOps to run its EIDOS immunotherapy patient selection service. Ellogon AI uses UbiOps as its ML and Data Science Platforms layer to deliver AI based pathology image analysis as a scalable SaaS to hospitals in the Netherlands and internationally.
The implementation configures UbiOps to host model serving containers, orchestrate inference pipelines, and expose stable API endpoints for clinical integration. Functional capabilities implemented on UbiOps include model deployment, batch and real time inference orchestration, data preprocessing pipelines, and service monitoring consistent with ML and Data Science Platforms functional patterns.
UbiOps provided cloud provider independence and easy scaling, enabling Ellogon AI to move the EIDOS solution from pilot and testing into clinical implementation around 2023. The deployment operates as a SaaS delivery model for healthcare and diagnostics workflows, supporting pathology image ingestion, automated scoring, and patient selection pipelines for hospitals in the Netherlands and internationally.
Operational governance was adapted for clinical rollout with controlled model promotion, environment separation for testing and production, and monitoring and alerting for inference performance and availability. Using UbiOps accelerated Ellogon AI go to market, and the full UbiOps implementation is positioned to support ongoing clinical deployments and iterative model updates.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||